Analysts Pick Top 10 ASCO Abstracts To Watch
Executive Summary
Looking ahead to the upcoming American Society of Clinical Oncology meeting, analysts flag abstracts on PD-1+PD-L1 combination data from AstraZeneca and studies in areas of high unmet need, like ovarian and pancreatic cancers, and EGFR-positive, T790-mutated lung cancer.